Novavax Covid vaccine shown to be nearly 90% effective in UK trial
by Sarah Boseley and Nicola Davis from Science | The Guardian on (#5DF8X)
Government has ordered 60m doses of jab, which appears to work well against Kent variant
Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus.
The UK vaccines taskforce has bought 60m doses of the Novavax vaccine, one of seven in its portfolio, and it will be manufactured on Teesside in the UK. If it is given emergency authorisation by the UK regulator, it could boost the country's immunisation programme and solve the potential problems over the supply of the other two vaccines in use.
Continue reading...